Alphabet's Twin Capital Push: Borrowing for Clouds, Raising Equity for Cures

Alphabet issues $18.5B in debt for AI compute while biotech arm Isomorphic Labs raises $2.7B. Google Cloud revenue surges 63%, stock hits 52-week high.

Alphabet is sending a clear signal that its AI ambitions require financing from every available source — debt markets for computing infrastructure and venture capital for drug discovery. On one side, the parent company just raised nearly $18.5 billion in new bond issuance across euros, Canadian dollars and yen. On the other, its biotech offshoot Isomorphic Labs closed a funding round that pushes external capital to roughly $2.7 billion, with heavyweights like Thrive Capital, Temasek and the UK's Sovereign AI Fund coming aboard.

Isomorphic Labs, led by Nobel laureate Demis Hassabis, is applying generative AI to slash drug development timelines. The company’s proprietary IsoDDE platform has already shown a leap in predictive accuracy: it models antigen-antibody interactions at 76% precision, versus AlphaFold 3’s 48%. The technology is being deployed across 17 active programs in oncology and immunology, and the business model leans on strategic alliances with Eli Lilly, Novartis, Johnson & Johnson and AstraZeneca — deals carrying potential milestone payments of up to $3 billion. By the end of 2026, Isomorphic Labs aims to launch its own clinical trials, effectively morphing from a platform provider into a phase-stage biotech.

The bond market activity, by contrast, is all about raw capacity. Alphabet issued €9 billion in euro-denominated notes and $9.5 billion in Canadian-dollar senior notes, with a yen-denominated series under preparation. This may seem odd for a company sitting on $126.8 billion in cash and marketable securities, but CEO Sundar Pichai has been explicit: demand for cloud and AI services outstrips what Alphabet can currently supply. Bridgewater Associates estimates that Alphabet, together with Amazon, Meta and Microsoft, could collectively pour $650 billion into AI infrastructure.

Nowhere is the crunch more visible than in Google Cloud. First-quarter revenue from the segment surged 63% year over year, and the backlog swelled past $460 billion. The overall corporate numbers underscore the financial firepower to fund this expansion: diluted earnings per share hit $5.11, revenue climbed to $109.9 billion, and net income jumped 81% to $62.6 billion. The 20% rise in total group revenue to nearly $110 billion was propelled by Google Cloud crossing the $20 billion quarterly mark for the first time.

Investors have rewarded the dual strategy of borrowing to scale compute while incubating high-risk, high-reward ventures. Alphabet shares closed Thursday at €344.60 in Frankfurt, a fresh 52-week high, with a year-to-date advance of 28% and the stock trading 38% above its 200-day moving average. The next catalyst arrives May 19, when the company hosts its Google I/O developer conference and is expected to detail deeper integration of its Gemini AI across the product portfolio. For now, Alphabet is buying capacity on one front and buying time on another — and the market is buying the story.